The National Times - Tech firms lead Asian markets rally as Seoul, Tokyo hit records

Tech firms lead Asian markets rally as Seoul, Tokyo hit records


Tech firms lead Asian markets rally as Seoul, Tokyo hit records
Tech firms lead Asian markets rally as Seoul, Tokyo hit records / Photo: © AFP

Stock markets in Seoul and Tokyo surged to record highs as tech firms led an Asia-wide rally Wednesday following a rebound in their counterparts on Wall Street.

Change text size:

Investors built on a broadly healthy week in the region as they piled onto the artificial intelligence bandwagon amid a shift from New York, where there is growing concern about elevated valuations as well as US political and economic uncertainty.

They are also keeping an eye on President Donald Trump's State of the Union address, which comes after his tariff policy was dealt a body blow by the Supreme Court on Friday and as he considers strikes on Iran.

Wall Street's tech titans including Magnificent Seven stalwarts have struggled in 2026 to match the past two years' eye-watering performance, with questions being asked about the vast sums they have invested in AI and when they will see returns.

Fresh worries about the recent release of tools that could hammer software firms have compounded the problems.

The latest blow came from a report Sunday by Citrini Research that used possible scenarios set in the future showing parts of the global economy that could be at risk from new tools, such as credit card and food delivery firms.

But a presentation by AI company Anthropic emphasising the compatibility of its technology with existing programmes tempered some fears, analysts said.

An announcement that Facebook parent Meta had reached an agreement to buy millions of chips from processor-maker AMD also lifted optimism.

Focus is now on the release of earnings from chip behemoth Nvidia later in the day, with analysts saying they could have an outsized impact on markets.

But Matt Weller at City Index warned: "Put simply, 'meeting' earnings expectations is unlikely to be enough to drive the stock higher, especially if conservative guidance reinforces some traders' fears that demand for AI (capital expenditure) may be downshifting."

A rally on all three main bourses on Wall Street provided a healthy lead for Asia, which has also enjoyed a lift from the Supreme Court's tariff announcement.

Seoul's Kospi jumped past 6,000 points for the first time, led once again by chip titans Samsung and SK hynix. The index has surged more than 40 percent this year, having rallied 76 percent in 2025.

Tokyo piled on more than one percent to also hit a new peak, with tech firms Advantest and Tokyo Electron among the best performers.

Taipei's gains were supported by Taiwan Semiconductor Manufacturing Company.

Hong Kong, Shanghai, Sydney and Wellington were also higher.

The yen was steady against the dollar after sinking Tuesday on media reports that Japanese Prime Minister Sanae Takaichi last week told Bank of Japan boss Kazuo Ueda of her concern about hiking interest rates further.

The Mainichi newspaper said she had taken a "tougher stance" than in their November meeting.

- Key figures at around 0200 GMT -

Tokyo - Nikkei 225: UP 1.5 percent at 58,182.00

Hong Kong - Hang Seng Index: UP 0.4 percent at 26,689.40

Shanghai - Composite: UP 0.5 percent at 4,136.09

Dollar/yen: DOWN at 155.70 yen from 155.74 yen on Tuesday

Euro/dollar: DOWN at $1.1779 from $1.1783

Pound/dollar: DOWN at $1.3502 from $1.3508

Euro/pound: DOWN at 87.21 pence from 87.23 pence

West Texas Intermediate: UP 0.6 percent at $66.05 per barrel

Brent North Sea Crude: UP 0.7 percent at $71.23 per barrel

New York - Dow: UP 0.8 percent at 49,174.50 (close)

London - FTSE 100: FLAT at 10,680.59 (close)

L.A.Adams--TNT

Featured

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Could gas prices return to 2022 highs on US-Iran war?

European gas prices have more than doubled owing to the US-Iran war, just as Europe needs to replenish its reserves ahead of winter.

Change text size: